Skip secondary menu

NINDS Neuroscience Funding Announcements



Proteomics and Metabolomics in Type 1 Diabetes and its Complications

Funding Contact: NINDS Funding Coordinator
Funding Categories: Systems and Cognitive Neuroscience

Brief Description:

Encouraging the scientific community to use proteomics technologies to study type 1 diabetes (T1D) and its complications. Proteomic technologies have been successfully used for the identification of cancer biomarkers, for the identification of novel drug targets and for studying several biological processes relevant to human health. High throughput metabolic profiling has been recently implemented for metabolomic studies. However, as of today these technologies have been applied to study T1D and its complication only in a limited way. Moreover, currently available proteomic and metabolomic technologies represent a great opportunity for advancing the field of T1D and its complications.



NIH Guide: RFA-DK-03-024
Release Date: 2003-10-24
Expiration Date: 2004-03-19